Abstract Details
Jennifer A. Roggenbuck, MS, CGC
(Ohio State University)
PRESENTER |
The institution of Ms. Roggenbuck has received research support from Packard Foundation. |
No disclosure on file | |
Stanley J. Iyadurai, MD, PhD, FAAN (Johns Hopkins All Children's Hospital/Catalyst) | Dr. Iyadurai has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Dr. Iyadurai has received stock or an ownership interest from Catalyst Pharmaceuticals. |
No disclosure on file | |
Stephen J. Kolb, MD, PhD (The Ohio State University) | Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH. |
John T. Kissel, MD, FAAN | Dr. Kissel has nothing to disclose. |